SYRE · Spyre Therapeutics, Inc. · Off Exchange
$99.23
+0.18 (+0.18%)
At close · Oct 28
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 4, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We will need to raise additional capital to continue to fund our operations in the future. If we are unable to raise additional capital when needed, we will not be able to continue as a going concern.”View the 10-Q filed Aug 4, 2026
Market Cap
$8.72B
Shares
88.17M
Volume · Oct 28
722.56K
Avg daily vol (3M)
1.21M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-09-21 | 1,625,627 | 865,137 | 2,490,764 | 42.4% |
| 2026-09-14 | 1,635,239 | 998,770 | 2,634,009 | 32.9% |
| 2026-09-07 | 1,169,855 | 377,523 | 1,547,378 | 38.3% |
| 2026-08-31 | 1,844,769 | 1,201,844 | 3,046,613 | 46.4% |
| 2026-08-24 | 2,237,411 | 1,295,709 | 3,533,120 | 49.7% |
| 2026-08-17 | 1,471,607 | 966,515 | 2,438,122 | 51.6% |
| 2026-08-10 | 1,127,085 | 476,770 | 1,603,855 | 42.8% |
| 2026-08-03 | 1,196,715 | 424,594 | 1,621,309 | 43.2% |
| 2026-07-27 | 1,592,347 | 671,136 | 2,263,483 | 46.5% |
| 2026-07-20 | 1,147,586 | 461,651 | 1,609,237 | 45.1% |
| 2026-07-13 | 2,444,498 | 1,337,329 | 3,781,827 | 48.5% |
| 2026-07-06 | 1,959,717 | 678,883 | 2,638,600 | 43.7% |
| 2026-06-29 | 2,340,061 | 671,459 | 3,011,520 | 49.1% |
| 2026-06-22 | 4,749,583 | 2,516,227 | 7,265,810 | 45.3% |
| 2026-06-15 | 1,612,417 | 680,622 | 2,293,039 | 35.5% |
| 2026-06-08 | 2,277,755 | 718,340 | 2,996,095 | 51.3% |
| 2026-06-01 | 1,986,795 | 1,177,180 | 3,163,975 | 52.6% |
| 2026-05-25 | 615,525 | 350,789 | 966,314 | 37.5% |
| 2026-05-18 | 1,806,190 | 594,188 | 2,400,378 | 49.3% |
| 2026-05-11 | 1,372,080 | 1,750,058 | 3,122,138 | 49.7% |
| 2026-05-04 | 1,562,735 | 1,076,312 | 2,639,047 | 48.0% |
| 2026-04-27 | 1,944,598 | 1,291,574 | 3,236,172 | 53.3% |
| 2026-04-20 | 1,508,765 | 603,082 | 2,111,847 | 45.6% |
| 2026-04-13 | 5,017,675 | 2,444,810 | 7,462,485 | 48.0% |
| 2026-04-06 | 1,138,548 | 384,514 | 1,523,062 | 40.9% |
| 2026-03-30 | 687,132 | 521,618 | 1,208,750 | 39.2% |
| 2026-03-23 | 1,306,753 | 612,289 | 1,919,042 | 44.3% |
| 2026-03-16 | 1,356,778 | 554,579 | 1,911,357 | 38.8% |
| 2026-03-09 | 1,258,488 | 267,469 | 1,525,957 | 41.6% |
| 2026-03-02 | 1,203,227 | 212,743 | 1,415,970 | 39.4% |
| 2026-02-23 | 1,042,918 | 280,297 | 1,323,215 | 38.0% |
| 2026-02-16 | 1,292,901 | 732,442 | 2,025,343 | 45.4% |
| 2026-02-09 | 1,204,397 | 466,395 | 1,670,792 | 46.0% |
| 2026-02-02 | 917,595 | 214,059 | 1,131,654 | 36.9% |
| 2026-01-26 | 620,113 | 171,320 | 791,433 | 36.0% |
| 2026-01-19 | 752,152 | 265,838 | 1,017,990 | 43.1% |
| 2026-01-12 | 814,604 | 591,606 | 1,406,210 | 39.9% |
| 2026-01-05 | 942,736 | 337,283 | 1,280,019 | 38.2% |
| 2025-12-29 | 444,316 | 269,793 | 714,109 | 33.0% |
| 2025-12-22 | 709,320 | 144,724 | 854,044 | 37.1% |
| 2025-12-15 | 1,214,733 | 1,310,033 | 2,524,766 | 39.5% |
| 2025-12-08 | 1,367,168 | 721,396 | 2,088,564 | 46.8% |
| 2025-12-01 | 1,434,149 | 381,405 | 1,815,554 | 42.1% |
| 2025-11-24 | 626,257 | 331,322 | 957,579 | 36.0% |
| 2025-11-17 | 738,327 | 234,117 | 972,444 | 33.2% |
| 2025-11-10 | 683,043 | 334,279 | 1,017,322 | 38.8% |
| 2025-11-03 | 970,156 | 532,654 | 1,502,810 | 41.4% |
Showing 1–47 of 47 weeks
Key facts
CIK
1636282
CUSIP
00773J202
13F (30d)
27 filings
27 filers
Visit website
Investor relations